Article Sidebar

PDF
Date Published: 10/02/2023
Abstract Views: 317
Views PDF: 164
DOI: https://doi.org/10.51298/vmj.v520i1B.3867
Issue
Vol. 520 No. 1B (2022)
Section
Các bài báo
How to Cite
Đỗ , T. Q. T., Bùi , T. X. V., Trần , T. N. L., & Châu , H. H. (2023). EVALUATION OF NERVE INJURY SCORES IN THE FEET OF PATIENTS WITH TYPE 2 DIABETES AND RISK FACTORS. Vietnam Medical Journal, 520(1B). https://doi.org/10.51298/vmj.v520i1B.3867

EVALUATION OF NERVE INJURY SCORES IN THE FEET OF PATIENTS WITH TYPE 2 DIABETES AND RISK FACTORS

Thị Quốc Trinh Đỗ 1,, Thị Xuân Vũ Bùi 1, Thị Ngọc Liên Trần 1, Hữu Hầu Châu 1
1 Nhat Tan General Hospital

Main Article Content

Abstract

Objective: Determine the Neuropathy Disability Score (NDS) in patients with type 2 diabetes to have appropriate treatment. Subjects and Methods: A prospective, cross-sectional study on 202 outpatients with type 2 diabetes who came for follow-up visits and hospitalized patients for 3 months from May 10 to September 9, 2022 at Nhat Tan hospital, Chau Doc city, An Giang province. Results: The proportion of people with NDS due to type 2 diabetes (T2DM) was 20.8%. Patients with chronic T2DM had a higher risk of NDS with OR=1.12 (95% CI, 1.06-1.18, p<0.001); the height contributed to increase NDS with OR=1.12 (CI 95%, 1.05-1.19; p <0.001); Hyperglycemia causes oxidative stress to damage neurons with OR=1.00 (KTC95%, 1.00-1.01, p < 0.05); The lower the weight, the lower the NDS was OR=0.91 (95% CI, 0.87 to 0.96, p<0.001); and HDL-Cholesterol contributed to the reduction in the NDS with OR=0.249 (95% CI, 0.09 to 0.63, p). <0.05). Conclusion: Chronic hyperglycemia can lead to circulatory, nervous and immune system disorders. It is necessary to recognize the NDSs early so that treatment can be taken to alleviate severe neurological complications that can cause disability to the patient.

Article Details

Keywords

Type 2 Diabetes Mellitus (T2DM), Neuropathy Disability Score (NDS)

References

1. Sun H, Saeedi P, Karuranga S, Pinkepank M et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes research and clinical practice 183 (2022) 109-119
2. Robertson RP, Nathan DM, Mulder JE. Type 2 diabetes mellitus: Prevalence and risk factors. UpToDate. Jan 25, 2022.
3. Hunaifi I, Agustriadi IGNO, Asmara IGY, Budyono C. The Correlation Between HbA1c and Neuropathy Disability Score in Type 2 Diabetes . Acta Med Indones - Indones J Intern Med • Vol 53 • Number 2 • April 2021
4. Boulton AJM. Management of Diabetic Peripheral Neuropathy. Clinical Diabetes • Volume 23, Number 1, 2005
5. Wexler DJ, Nathan DM, Mulder JE. Evaluation of the diabetic foot. UpToDate, Jan 2021
6. Mythili A, Kumar KD, Subrahmanyam KAV, Venkateswarlu K, Butchi RG. A Comparative study of examination scores and quantitative sensory testing in diagnosis of diabetic polyneuropathy. Int J Diabetes Dev Ctries. 2010 Jan-Mar; 30(1): 43–48.
7. Kiani J, Moghimbeigi A, Azizkhani H, Kosarifard S. The prevalence and associated risk factors of peripheral diabetic neuropathy in Hamedan, Iran. 2013 Jan;16(1):17-9.
8. Sujjay J, Green SR, Kasim K. Height is a risk factor for development of peripheral insensate neuropathy. Medicine Int J Adv Med. 2019 Jun;6(3):860-866.
9. Cai Z, Yang Y, Zhang J. A systematic review and meta-analysis of the serum lipid profile in prediction of diabetic neuropathy. Scientifc Reports | (2021) 11:499.